Gunzburg announced the creation of a vaccine against three new types of "omicron"
Academician Alexander Gunzburg proposes to speed up the registration of the vaccine, because the existing procedure takes up to six months. According to the scientist, the virus neutralization of "Sputnik V" against the subspecies "omicron" BA.
As RDIF CEO Kirill Dmitriev told RBC, Sputnik V has become the most exported drug in Russian history since its registration. In addition, with the support of the investment fund, the production of the drug was organized abroad. In total, Sputnik V was registered in 71 countries of the world. However, it has not been recognized by the World HEALTH Organization.
The HEAD of the Gamaleya Center Alexander Gintsburg told RBC about the creation of a new subvalent platform "Sputnik V" against three new types of "omicron" (BA.1, BA.2, BA.5). However, according to him, it will not be possible to quickly implement it according to the current rules.
“The platform has been created, now the issue of regulation is not clear how the tests will be carried out. According to the current rules, the tests will take five to six months. But during this time, a new strain will appear,” Gunzburg said.
In his opinion, this problem could be solved by changing the existing rules. “In order for us not to register a new vaccine, but to change the antigenic strain in an existing one, this process needs to take a month,” he said.
Also head of the Center. Gamalei told RBC that he had already taken root in a new development that protects against "omicron".
In RUSSIA, for the first time since June, more than 60 deaths from covid-19 were detected per day Society
Gunzburg explained the need for a new platform by the fact that the virus neutralization of the registered Sputnik V against the BA.5 subspecies of omicron fell tenfold. WHO considers such indicators in the case of influenza as grounds for changing the vaccine strain. “If we wait some more time, we will have to develop a new platform, not against Omicron, but against some new strains,” the scientist said.
On August 11, the operational headquarters for the fight against CORONAVIRUS reported that 25,815 new cases of infection were detected in Russia, which was the maximum since March 23. 2525 people were hospitalized, 52 died.
Read on RBC Pro Pro “Why are we so poor?”:how to answer uncomfortable questions from a child Instructions Pro What does the Swiss tax system offer to Russian businessmen:Overview Articles Pro From 2009 to 2022:how offices in Moscow were tempered in criseshow to stop following imposed goals Summary Pro Why we like thrillers and horror movies:says a neurophysiologist Articles Pro Will banking transactions be protected after the departure of the French Thales Articles ProQ-commerce: what awaits fast delivery services Articles Pro Dismiss and take back:how to formalize an employment relationship with the DIRECTOR of LLC InstructionsAccording to Rospotrebnadzor, BA4 and BA5 strains now dominate in Russia, which have replaced the Omicron variant and the Delta strain, which prevailed at the end of last year and the beginning of this year. They account for more than 82% of cases.
Russian President Vladimir Putin announced the registration of the first Russian vaccine against coronavirus infection exactly two years ago, on August 11, 2020. The two-component drug was developed by the National Research Center for Epidemiology and Microbiology. N.F. Gamalei (NICEM).
In Russia, for the first time in five months, more than 25 thousand people infected with covid were detected Society
As RDIF CEO Kirill Dmitriev told RBC, Sputnik V has become the most exported drug in Russian history since its registration. In addition, with the support of the investment fund, the production of the drug was organized abroad. In total, Sputnik V was registered in 71 countries of the world. However, it has not been recognized by the World HEALTH Organization.
In mid-July, RBC wrote about a study by scientists from the European University at St. Petersburg and the Medical Institute. Berezin on the effectiveness of Russian vaccines against lung damage against the background of the spread of Delta and Omicron strains. According to the results of the study, the effectiveness of the two-dose EpiVacCoron vaccine against lung damage was 2%, the same indicator for three doses of Sputnik V (vaccination with two doses plus revaccination with a single-dose Sputnik Light) is 71%, for two doses of the CoviVac vaccine - 46%.